Assenagon Asset Management S.A. Immunovant, Inc. Transaction History

Assenagon Asset Management S.A.

  • $47.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024
BUY
$25.1 - $31.61 $5.2 Million - $6.54 Million
207,003 Added 198.05%
311,525 $8.22 Million
Q1 2024

Apr 24, 2024
SELL
$30.27 - $43.79 $506,901 - $733,307
-16,746 Reduced 13.81%
104,522 $3.38 Million
Q4 2023

Jan 17, 2024
BUY
$31.31 - $44.19 $3.8 Million - $5.36 Million
121,268 New
121,268 $5.11 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email